Elrexfio
These highlights do not include all the information needed to use ELREXFIO safely and effectively. See full prescribing information for ELREXFIO. ELREXFIO (elranatamab-bcmm) injection, for subcutaneous useInitial U.S. Approval: 2023
f6fea598-ff58-4a20-b5e8-8a51f37d8beb
HUMAN PRESCRIPTION DRUG LABEL
Aug 15, 2023
Pfizer Laboratories Div Pfizer Inc
DUNS: 134489525
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
elranatamab-bcmm
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
elranatamab-bcmm
Product Details
FDA regulatory identification and product classification information